查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
創傷後應激障礙治療市場規模、份額和趨勢分析報告：按藥物類別、人口統計數據（成人、兒童）、分銷渠道、地區、細分市場預測，2022-2030 年
市場調查報告書
商品編碼
1170944

創傷後應激障礙治療市場規模、份額和趨勢分析報告：按藥物類別、人口統計數據（成人、兒童）、分銷渠道、地區、細分市場預測，2022-2030 年

Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics (Adult, Children), By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

創傷後應激障礙治療市場的增長和趨勢

根據 Grand View Research, Inc. 的一份新報告預測，從 2022 年到 2030 年，全球創傷後應激障礙治療市場規模的複合年增長率將達到 4.7%，到 2030 年將達到 14 億美元。 創傷後應激障礙 (PTSD) 的疾病負擔不斷增加、研發和新藥管線的創新以及政府和非營利組織為提高認識所做的努力是推動該領域增長的關鍵因素。它是

預計在預測期內，用於治療 PTSD 的有前途的新藥管道將為市場增長提供有利可圖的機會。 這是由於 Aptinyx 的 NYX-783、Bionomics 的 BNC210 和 Jazz Pharmaceuticals 的 JZP150 正在進行二期臨床試驗。 此外，Otsuka Pharmaceutical 的 Breexpiprazole 和 Zoloft 聯合療法正處於 3 期試驗階段，各大公司之間為將產品推向該領域的市場展開了激烈的競爭。

COVID-19 大流行等事件進一步推動了該行業的發展。 已經進行了幾項研究來了解 COVID-19 大流行對心理健康的影響，增加了 PTSD 的風險並增加了對其治療的需求。 例如，2021 年 8 月的評論文章“COVID-19 和創傷後應激障礙”。明確指出

公司正在採取戰略措施，通過新產品開發、監管審批和地域擴張來幫助擴展其產品組合。 例如，2022 年 3 月，H. Lundbeck A/S 授予 Sun Pharmaceutical Industries Ltd.許可協議，在印度市場以 Vortidiftm 品牌營銷和分銷 Vortioxetine。

創傷後應激障礙治療市場報告重點

在 Zoloft（捨曲林）和 Paxil（帕羅西汀）等 FDA 批准的 SSRI 的推動下，預計 2021 年抗抑鬱藥細分市場將佔據最大份額並在預測期內保持其地位

根據人口統計數據，由於老年病發病率上升、老年病患病率高以及外傷經歷增加，預測期內復合年增長率為 5.1%，預計將是最快的。

按銷售渠道劃分，由於長期家庭護理的可用性和適用性等因素，零售藥店將在 2021 年主導市場份額。

亞太地區預計在預測期內增長最快，原因是發展中國家的人口意識提高、可支配收入增加以及 PTSD 患病率高

內容

第1章調查方法及範圍

  • 市場細分和範圍
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析
      • 方法：產品流方法
  • 調查假設
  • 次要信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場前景

第 3 章創傷後應激障礙治療市場變量、趨勢和範圍

  • 描繪滲透率和增長前景
  • 用戶視角分析
  • 監管和報銷框架
  • 市場驅動因素分析
    • PTSD 患病率上升
    • 增加研發以開發新療法
  • 市場製約因素分析
    • 與藥物有關的副作用
  • COVID-19 影響分析
  • SWOT 分析，按因素（政治和法律、經濟、技術）
  • 行業分析 - 搬運工

第 4 章。創傷後應激障礙治療市場：細分分析，按藥物類別，2018-2030 年（百萬美元）

  • 創傷後應激障礙治療市場：藥物類別的波動分析
  • 抗抑鬱藥
  • 抗精神病藥
  • 抗焦慮
  • 其他

第 5 章創傷後應激障礙治療市場：細分分析，按人口統計，2018-2030 年（百萬美元）

  • 創傷後應激障礙治療市場：人口變化分析
  • 成人
  • 孩子們

第 6 章創傷後應激障礙治療市場：細分分析，按分銷渠道，2018-2030 年（百萬美元）

  • 創傷後應激障礙治療市場：分銷渠道的變化分析
  • 醫院藥房
  • 零售藥房
  • 其他

第 7 章。創傷後應激障礙治療市場：細分分析，按地區劃分，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2021 年和 2030 年區域市場份額分析
  • 區域市場概況
  • 2021-2030 年市場規模、預測、收入和趨勢分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 意大利
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 澳大利亞
      • 韓國
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 8 章創傷後應激障礙治療市場：競爭分析

  • 主要市場進入者的近期趨勢和影響分析
    • 新產品發布
    • 併購
    • 夥伴關係和戰略協作
    • 會議和活動
  • 公司分類
    • 創新者
    • 市場領導者
    • 熱圖分析
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
  • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 公司市場分析
    • 競爭儀表板分析
      • 市場差異化因素
  • 私人公司
    • 主要初創企業名單
    • 本地網絡地圖
  • 公司簡介
    • 盧平有限公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 輝瑞公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Aurobindo 製藥有限公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 默克集團
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 葛蘭素史克公司
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 大塚製藥開發
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 爵士製藥
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 生物經濟學
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Aptinyx
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 阿斯利康
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-997-2

Post-traumatic Stress Disorder Treatment Market Growth & Trends:

The global post-traumatic stress disorder treatment market size is expected to reach USD 1.4 billion by 2030, registering a CAGR of 4.7% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of post-traumatic stress disorder (PTSD), innovation in R&D and emerging drug pipeline, and efforts by government and non-profit organizations to increase awareness are the key factors augmenting the space growth.

The emerging drug pipeline, thereby, expected advancement and drug launches for the treatment of PTSD, is anticipated to offer a lucrative opportunity for market growth over the forecast period. This can be attributed to the presence of Aptinyx's NYX-783, Bionomics' BNC210, and Jazz Pharmaceuticals' JZP150 under phase 2 clinical trials. Ahead of these, Otsuka Pharmaceutical's Brexpiprazole and Zoloft Combination are in phase 3 trial, creating fierce competition among key players to launch the product in the space.

Events such as the COVID-19 pandemic further support space growth. Several studies have been conducted to understand the impact of the COVID-19 pandemic on mental health, increasing the risk of PTSD and rising demand for its treatment. For instance, the August 2021 review article, "COVID?19 and Post traumatic Stress Disorder: The Perfect 'Storm' for Mental Health," clearly demonstrates an increase in the risk of development of PTSD among pandemic affected families and survivors.

Companies are strategically taking initiatives that aid in developing new products, regulatory approvals, and enhancing their product portfolio with geographical expansion. For instance, in March 2022, H. Lundbeck A/S granted the license agreement to Sun Pharmaceutical Industries Ltd., for marketing and distribute of Vortioxetine under the brand name Vortidiftm in the Indian market.

Post-traumatic Stress Disorder Treatment Market Report Highlights:

  • In 2021, antidepressants segment accounted for the largest share and is anticipated to maintain its position over the forecast period owing to FDA approved SSRIs such as Zoloft (sertraline) and Paxil (paroxetine)
  • Based on demographics, adult segment is estimated to witness the fastest CAGR of 5.1% during the forecast period owing to presence of rising disorder incidence in adult group, major chunk of patients in this age group and increase in traumatic experiences
  • Based on distribution channel, retail pharmacy segment dominated the space in 2021, due to factors such easy of availability, and its compatibility with homecare setting for the long term treatment
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increased awareness among the population, rise in disposable income, and high disease prevalence of PTSD in developing countries

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Post-Traumatic Stress Disorder Treatment Market Variables, Trends, And Scope

  • 3.1 Penetration And Growth Prospect Mapping
  • 3.2 User Perspective Analysis
  • 3.3 Regulatory And Reimbursement Framework
  • 3.4 Market Driver Analysis
    • 3.4.1 Rising Prevalence Of The Ptsd
    • 3.4.2 Increasing R&D For Development Of New Therapies
  • 3.5 Market Restraint Analysis
    • 3.5.1 Side Effects Associated With Drugs
  • 3.6 Covid-19 Impact Analysis
  • 3.7 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.8 Industry Analysis - Porter's

Chapter 4 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Drug Class, 2018 - 2030 (USD Million)

  • 4.1 Post-Traumatic Stress Disorder Treatment Market: Drug Class Movement Analysis
  • 4.2 Antidepressants
    • 4.2.1 Antidepressants Market, 2018 - 2030 (USD Million)
  • 4.3 Antipsychotics
    • 4.3.1 Antipsychotics Market, 2018 - 2030 (USD Million)
  • 4.4 Anti-Anxiety
    • 4.4.1 Anti-Anxiety Market, 2018 - 2030 (USD Million)
  • 4.5 Others
    • 4.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Demographics, 2018 - 2030 (USD Million)

  • 5.1 Post-Traumatic Stress Disorder Treatment Market: Demographics Movement Analysis
  • 5.2 Adult
    • 5.2.1 Adult Market, 2018 - 2030 (USD Million)
  • 5.3 Children
    • 5.3.1 Children Market, 2018 - 2030 (USD Million)

Chapter 6 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Post-Traumatic Stress Disorder Treatment Market: Distribution Channel Movement Analysis
  • 6.2 Hospital Pharmacy
    • 6.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3 Retail Pharmacy
    • 6.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2021 & 2030
  • 7.3 Regional Market Snapshot
  • 7.4 Market Size, & Forecasts, Revenue And Trend Analysis, 2021 to 2030
    • 7.4.1 North America
      • 7.4.1.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.1.2 U.S.
      • 7.4.1.2.1 U.S. Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.1.3 Canada
      • 7.4.1.3.1 Canada Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.2 Europe
      • 7.4.2.1 Europe Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.2 U.K.
      • 7.4.2.2.1 Uk Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.3 Germany
      • 7.4.2.3.1 Germany Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.4 France
      • 7.4.2.4.1 France Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.5 Spain
      • 7.4.2.5.1 Spain Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.6 Italy
      • 7.4.2.6.1 Italy Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.3 Asia Pacific
      • 7.4.3.1 Asia Pacific Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.2 Japan
      • 7.4.3.2.1 Japan Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.3 China
      • 7.4.3.3.1 China Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.4 India
      • 7.4.3.4.1 India Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.5 Australia
      • 7.4.3.5.1 Australia Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.6 South Korea
      • 7.4.3.6.1 South Korea Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.4 Latin America
      • 7.4.4.1 Latin America Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.4.2 Brazil
      • 7.4.4.2.1 Brazil Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.4.3 Mexico
      • 7.4.4.3.1 Mexico Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.4.4 Argentina
      • 7.4.4.4.1 Argentina Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.5 Middle East & Africa
      • 7.4.5.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.5.2 South Africa
      • 7.4.5.2.1 South Africa Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.5.3 Saudi Arabia
      • 7.4.5.3.1 Saudi Arabia Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.5.4 UAE
      • 7.4.5.4.1 UAE Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)

Chapter 8 Post-Traumatic Stress Disorder Treatment Market: Competitive Analysis

  • 8.1 Recent Developments And Impact Analysis, By Key Market Participants
    • 8.1.1 New Product Launches
    • 8.1.2 Mergers And Acquisitions
    • 8.1.3 Partnerships And Strategic Collaboration
    • 8.1.4 Conferences And Campaigns
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
    • 8.2.3 Heat Map Analysis
  • 8.3 Vendor Landscape
    • 8.3.1 List Of Key Distributors And Channel Partners
    • 8.3.2 Key Customers
  • 8.4 Key Company Market Share Analysis, 2021
  • 8.5 Public Companies
    • 8.5.1 Company Market Position Analysis
    • 8.5.2 Competitive Dashboard Analysis
      • 8.5.2.1 Market Differentiators
  • 8.6 Private Companies
    • 8.6.1 List Of Key Emerging Companies
    • 8.6.2 Regional Network Map
  • 8.7 Company Profiles
    • 8.7.1 Lupin Limited
      • 8.7.1.1 Company Overview
      • 8.7.1.2 Financial Performance
      • 8.7.1.3 Product Benchmarking
      • 8.7.1.4 Strategic Initiatives
    • 8.7.2 Pfizer, Inc.
      • 8.7.2.1 Company Overview
      • 8.7.2.2 Financial Performance
      • 8.7.2.3 Product Benchmarking
      • 8.7.2.4 Strategic Initiatives
    • 8.7.3 Aurobindo Pharma Limited
      • 8.7.3.1 Company Overview
      • 8.7.3.2 Financial Performance
      • 8.7.3.3 Product Benchmarking
      • 8.7.3.4 Strategic Initiatives
    • 8.7.4 Merck Kgaa
      • 8.7.4.1 Company Overview
      • 8.7.4.2 Financial Performance
      • 8.7.4.3 Product Benchmarking
      • 8.7.4.4 Strategic Initiatives
    • 8.7.5 Glaxosmithkline Plc
      • 8.7.5.1 Company Overview
      • 8.7.5.2 Financial Performance
      • 8.7.5.3 Product Benchmarking
      • 8.7.5.4 Strategic Initiatives
    • 8.7.6 Otsuka Pharmaceutical Development
      • 8.7.6.1 Company Overview
      • 8.7.6.2 Financial Performance
      • 8.7.6.3 Product Benchmarking
      • 8.7.6.4 Strategic Initiatives
    • 8.7.7 Jazz Pharmaceuticals
      • 8.7.7.1 Company Overview
      • 8.7.7.2 Financial Performance
      • 8.7.7.3 Product Benchmarking
      • 8.7.7.4 Strategic Initiatives
    • 8.7.8 Bionomics
      • 8.7.8.1 Company Overview
      • 8.7.8.2 Financial Performance
      • 8.7.8.3 Product Benchmarking
      • 8.7.8.4 Strategic Initiatives
    • 8.7.9 Aptinyx
      • 8.7.9.1 Company Overview
      • 8.7.9.2 Financial Performance
      • 8.7.9.3 Product Benchmarking
      • 8.7.9.4 Strategic Initiatives
    • 8.7.10 Astrazeneca
      • 8.7.10.1 Company Overview
      • 8.7.10.2 Financial Performance
      • 8.7.10.3 Product Benchmarking
      • 8.7.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviation
  • Table 3 List of Key Distributors
  • Table 4 List of Other Companies
  • Table 5 List of Key Emerging Companies/Demographics Disruptors/innovators
  • Table 6 Global Post-traumatic Stress Disorder Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 Global Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8 Global Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 9 Global Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 North America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 North America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 12 North America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 13 North America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 U.S. Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 15 U.S. Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 16 U.S. Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Canada Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 18 Canada Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 19 Canada Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Europe Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 22 Europe Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 23 Europe Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 U.K. Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 U.K. Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 26 U.K. Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 28 Germany Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 29 Germany Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 France Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 31 France Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 32 France Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Spain Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 34 Spain Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 35 Spain Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Italy Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Italy Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 38 Italy Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Japan Post-traumatic Stress Disorder Treatment Market, By Drug Class Type, 2018 - 2030 (USD Million)
  • Table 44 Japan Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 45 Japan Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 China Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 47 China Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 48 China Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 49 India Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 50 India Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 51 India Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 Australia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Australia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 54 Australia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 South Korea Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 56 South Korea Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 57 South Korea Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Latin America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 59 Latin America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 60 Latin America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 61 Latin America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Brazil Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 63 Brazil Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 64 Brazil Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Mexico Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 66 Mexico Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 67 Mexico Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 Argentina Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 69 Argentina Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 70 Argentina Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71 MEA Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 MEA Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 73 MEA Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 74 MEA Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 South Africa Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 76 South Africa Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 77 South Africa Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 81 UAE Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 82 UAE Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 83 UAE Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Post-traumatic stress disorder treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2020)
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 User perspective analysis
  • Fig. 12 Post-traumatic stress disorder treatment market driver impact
  • Fig. 11 Prevalence of PTSD by WHO regions (in 2021)
  • Fig. 12 Post-traumatic stress disorder treatment market restraint impact
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Post-traumatic stress disorder treatment market drug class outlook: Key takeaways
  • Fig. 16 Post-traumatic stress disorder treatment market: Drug class movement analysis
  • Fig. 17 Antidepressants market, 2018 - 2030 (USD million)
  • Fig. 18 Antipsychotics market, 2018 - 2030 (USD million)
  • Fig. 19 Anti-anxiety market, 2018 - 2030 (USD million)
  • Fig. 20 Others market, 2018 - 2030 (USD million)
  • Fig. 21 Post-traumatic stress disorder treatment market demographics outlook: Key takeaways
  • Fig. 22 Post-traumatic stress disorder treatment market: Demographics movement analysis
  • Fig. 23 Adult market, 2018 - 2030 (USD million)
  • Fig. 24 Children market, 2018 - 2030 (USD million)
  • Fig. 25 Post-traumatic stress disorder treatment market distribution channel outlook: Key takeaways
  • Fig. 26 Post-traumatic stress disorder treatment market: Distribution channel movement analysis
  • Fig. 27 Hospital pharmacy market, 2018 - 2030 (USD million)
  • Fig. 28 Retail pharmacy market, 2018 - 2030 (USD million)
  • Fig. 29 Others market, 2018 - 2030 (USD million)
  • Fig. 30 Regional outlook, 2021 & 2030
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America
  • Fig. 33 North America post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S.
  • Fig. 35 U.S. post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada
  • Fig. 37 Canada post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe
  • Fig. 39 Europe post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 U.K.
  • Fig. 41 U.K. post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany
  • Fig. 43 Germany post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 France
  • Fig. 45 France post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain
  • Fig. 47 Spain post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy
  • Fig. 49 Italy post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific
  • Fig. 51 Asia Pacific post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan
  • Fig. 53 Japan post-traumatic stress disorder treatment market et, 2018 - 2030 (USD Million)
  • Fig. 54 China
  • Fig. 55China post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 India
  • Fig. 57 India post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia
  • Fig. 59 Australia post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea
  • Fig. 61 South Korea post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America
  • Fig. 63 Latin America post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil
  • Fig. 65 Brazil post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico
  • Fig. 67 Mexico post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina
  • Fig. 69 Argentina post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East & Africa
  • Fig. 71 Middle East & Africa post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa
  • Fig. 73 South Africa post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia
  • Fig. 75 Saudi Arabia post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE
  • Fig. 77 UAE post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 78 Heat map analysis
  • Fig. 79 Company market share analysis (2021)
  • Fig. 80 Company market position analysis (2021)
  • Fig. 81 Company market position analysis (2021)
  • Fig. 82 Market differentiators
  • Fig. 83 Regional network map